- Home
- Acne
- Eczema
- Seborrheic Dermatitis
- Onychomycosis
- Psoriasis
- Local Anaesthetics
- Photodynamic Therapy
- Contact Us
Copyright © 2021 Galenicum
At Galenicum Derma, our objective is to become a reference in the industry by offering a comprehensive product portfolio to address the main dermatological diseases. Our close relationships with dermatologists are key to our Research and Development team so as to develop innovative products, and guarantee their safety and effectiveness. We are a company with a global approach, with own sales team in Spain and Latin America, and ready for new partnerships around the globe.
First probiotic with clinical studies that significantly helps to reduce inflammatory skin lesions.
Learn about our range of solutions for problems associated with eczema and dermatitis, including inflammatory and itchy skin conditions.
We work with a treatment shampoo that helps to reduce discomfort on the scalp (excess sebum, itching, inflammation).
We have an antifungal lacquer that helps to treat fungal nail infections.
Discover how to reduce and improve skin irritation with the first probiotic for psoriasis with clinical studies.
Our lubricants and surface anaesthetics.
We use the photosensitisers that have shown the greatest efficacy in PDT.
We are focused on dermatology, commiting ourselves to pursue first-in-class and best-inclass therapies, whether through in-licensing or in our in-house R&D department.
Through innovation we take into consideration the opinion of dermatologist in order to help people improve their health and quality of life.
Quality is critical for the safety and efficacy of a pharmaceutical product. Our top priority is the health and safety of our patients.
The contents of this section are strictly directed to health professionals with practice in Spain and certified to prescribe pharmaceutical products, which require specialized training for their right interpretation. Please notice that pharmaceutical products might have a different summary of characteristics authorised in other countries.
If you click 'accept' you are acknowledging you are willing to access information targeting health professionals.
Pharmacovigilance telephone (24/7):
+34 603 796 658